Fully 70% of patients with nonactive secondary progressive multiple sclerosis (SPMS) who received foralumab nasal spray in an expanded access program (EAP) experienced a lessening in fatigue levels after six months of treatment.
Foralumab found to ease fatigue in SPMS ... - My MSAA Community
Foralumab found to ease fatigue in SPMS patients in access program
Written by
BettysMom
To view profiles and participate in discussions please or .
4 Replies
•
I don't have SPMS, but the concept of a DMT that reduces fatigue in a nasal spray is pretty interesting. Thanks.
that would be awesome. That’s pretty much where my MS is. I haven’t had a flare up in years, just trying to maintain the status quo. Fatigue is one of my biggest symptoms.
Good to see work on a drug for non relapsing SPMS.
Thanks for the information
Not what you're looking for?
You may also like...
Lipoic acid
Ibenmaor wrote that lipoic acid helps with fatigue. Is anyone taking it successfully for gait?...
DMTs in Aging MS Patients: When and How to Stop
The efficacy of disease-modifying therapies (DMTs) goes down with advancing age. One...
Blood Test for MS Activity Gets FDA Breakthrough Designation
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the...
Help- Ocrevus with spms?
Ok, this may be a long post because I need to vent and sort through what’s going on.
Background:...
No possible meds
Met with my MS doctor yesterday, and reviewed my MRI. No changes since 2013. Good I guess, but she...